Peptide Based Metabolic Disorders Therapeutics Global Market Report 2024

Peptide Based Metabolic Disorders Therapeutics Global Market Report 2024

Including: 1) By Drug Type: Liraglutide; Exenatide2) By Application: Lysosomal Storage Diseases; Diabetes; Obesity; Hypercholesterolemia3) By Distribution Channel: Hospital Pharmacies; Retail Pharmacies; Online PharmaciesCovering: Pfizer Inc.; Johnson And Johnson; Roche Holding AG; Merck And Co. Inc.; AbbVie Inc.


Peptide Based Metabolic Disorders Therapeutics Global Market Report 2024 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on peptide based metabolic disorders therapeutics market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase
  • Gain a truly global perspective with the most comprehensive report available on this market covering 50+ geographies.
  • Understand how the market has been affected by the COVID-19 and how it is responding as the impact of the virus abates.
  • Assess the Russia – Ukraine war’s impact on agriculture, energy and mineral commodity supply and its direct and indirect impact on the market.
  • Measure the impact of high global inflation on market growth.
  • Create regional and country strategies on the basis of local data and analysis.
  • Identify growth segments for investment.
  • Outperform competitors using forecast data and the drivers and trends shaping the market.
  • Understand customers based on the latest market shares.
  • Benchmark performance against key competitors.
  • Suitable for supporting your internal and external presentations with reliable high quality data and analysis
  • Report will be updated with the latest data and delivered to you within 3-5 working days of order along with an Excel data sheet for easy data extraction and analysis.
  • All data from the report will also be delivered in an excel dashboard format.
Description:

Where is the largest and fastest growing market for peptide based metabolic disorders therapeutics ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The peptide based metabolic disorders therapeutics market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market’s historic and forecast market growth by geography.
  • The market characteristics section of the report defines and explains the market.
  • The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
  • The forecasts are made after considering the major factors currently impacting the market. These include:
  • The impact of sanctions, supply chain disruptions, and altered demand for goods and services due to the Russian Ukraine war, impacting various macro-economic factors and parameters in the Eastern European region and its subsequent effect on global markets.
  • The impact of higher inflation in many countries and the resulting spike in interest rates.
  • The continued but declining impact of COVID-19 on supply chains and consumption patterns.
  • Market segmentations break down the market into sub markets.
  • The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers the growth trajectory of COVID-19 for all regions, key developed countries and major emerging markets.
  • The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
  • The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.
Scope

Markets Covered:1) By Drug Type: Liraglutide; Exenatide; Other Drug Type

2) By Application: Lysosomal Storage Diseases; Diabetes; Obesity; Hypercholesterolemia; Other Applications

3) By Distribution Channel: Hospital Pharmacies; Retail Pharmacies; Online Pharmacies

Companies Mentioned: Pfizer Inc.; Johnson And Johnson; Roche Holding AG; Merck And Co. Inc.; AbbVie Inc.

Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain

Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa

Time series: Five years historic and ten years forecast.

Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,

Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.

Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.

Delivery format: PDF, Word and Excel Data Dashboard.

Please Note: Report will be updated with the latest data and delivered to you within 3-5 working days of order.


1. Executive Summary
2. Peptide Based Metabolic Disorders Therapeutics Market Characteristics
3. Peptide Based Metabolic Disorders Therapeutics Market Trends And Strategies
4. Peptide Based Metabolic Disorders Therapeutics Market - Macro Economic Scenario
4.1. Impact Of High Inflation On The Market
4.2. Ukraine-Russia War Impact On The Market
4.3. COVID-19 Impact On The Market
5. Global Peptide Based Metabolic Disorders Therapeutics Market Size and Growth
5.1. Global Peptide Based Metabolic Disorders Therapeutics Market Drivers and Restraints
5.1.1. Drivers Of The Market
5.1.2. Restraints Of The Market
5.2. Global Peptide Based Metabolic Disorders Therapeutics Historic Market Size and Growth, 2018 - 2023, Value ($ Billion)
5.3. Global Peptide Based Metabolic Disorders Therapeutics Forecast Market Size and Growth, 2023 - 2028, 2033F, Value ($ Billion)
6. Peptide Based Metabolic Disorders Therapeutics Market Segmentation
6.1. Global Peptide Based Metabolic Disorders Therapeutics Market, Segmentation By Drug Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
Liraglutide
Exenatide
Other Drug Type
6.2. Global Peptide Based Metabolic Disorders Therapeutics Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
Lysosomal Storage Diseases
Diabetes
Obesity
Hypercholesterolemia
Other Applications
6.3. Global Peptide Based Metabolic Disorders Therapeutics Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
Hospital Pharmacies
Retail Pharmacies
Online Pharmacies
7. Peptide Based Metabolic Disorders Therapeutics Market Regional And Country Analysis
7.1. Global Peptide Based Metabolic Disorders Therapeutics Market, Split By Region, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
7.2. Global Peptide Based Metabolic Disorders Therapeutics Market, Split By Country, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
8. Asia-Pacific Peptide Based Metabolic Disorders Therapeutics Market
8.1. Asia-Pacific Peptide Based Metabolic Disorders Therapeutics Market Overview
Region Information, Impact Of COVID-19, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
8.2. Asia-Pacific Peptide Based Metabolic Disorders Therapeutics Market, Segmentation By Drug Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
8.3. Asia-Pacific Peptide Based Metabolic Disorders Therapeutics Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
8.4. Asia-Pacific Peptide Based Metabolic Disorders Therapeutics Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
9. China Peptide Based Metabolic Disorders Therapeutics Market
9.1. China Peptide Based Metabolic Disorders Therapeutics Market Overview
9.2. China Peptide Based Metabolic Disorders Therapeutics Market, Segmentation By Drug Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion
9.3. China Peptide Based Metabolic Disorders Therapeutics Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion
9.4. China Peptide Based Metabolic Disorders Therapeutics Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion
10. India Peptide Based Metabolic Disorders Therapeutics Market
10.1. India Peptide Based Metabolic Disorders Therapeutics Market, Segmentation By Drug Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
10.2. India Peptide Based Metabolic Disorders Therapeutics Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
10.3. India Peptide Based Metabolic Disorders Therapeutics Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
11. Japan Peptide Based Metabolic Disorders Therapeutics Market
11.1. Japan Peptide Based Metabolic Disorders Therapeutics Market Overview
11.2. Japan Peptide Based Metabolic Disorders Therapeutics Market, Segmentation By Drug Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
11.3. Japan Peptide Based Metabolic Disorders Therapeutics Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
11.4. Japan Peptide Based Metabolic Disorders Therapeutics Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
12. Australia Peptide Based Metabolic Disorders Therapeutics Market
12.1. Australia Peptide Based Metabolic Disorders Therapeutics Market, Segmentation By Drug Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
12.2. Australia Peptide Based Metabolic Disorders Therapeutics Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
12.3. Australia Peptide Based Metabolic Disorders Therapeutics Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
13. Indonesia Peptide Based Metabolic Disorders Therapeutics Market
13.1. Indonesia Peptide Based Metabolic Disorders Therapeutics Market, Segmentation By Drug Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
13.2. Indonesia Peptide Based Metabolic Disorders Therapeutics Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
13.3. Indonesia Peptide Based Metabolic Disorders Therapeutics Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
14. South Korea Peptide Based Metabolic Disorders Therapeutics Market
14.1. South Korea Peptide Based Metabolic Disorders Therapeutics Market Overview
14.2. South Korea Peptide Based Metabolic Disorders Therapeutics Market, Segmentation By Drug Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
14.3. South Korea Peptide Based Metabolic Disorders Therapeutics Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
14.4. South Korea Peptide Based Metabolic Disorders Therapeutics Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
15. Western Europe Peptide Based Metabolic Disorders Therapeutics Market
15.1. Western Europe Peptide Based Metabolic Disorders Therapeutics Market Overview
15.2. Western Europe Peptide Based Metabolic Disorders Therapeutics Market, Segmentation By Drug Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
15.3. Western Europe Peptide Based Metabolic Disorders Therapeutics Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
15.4. Western Europe Peptide Based Metabolic Disorders Therapeutics Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
16. UK Peptide Based Metabolic Disorders Therapeutics Market
16.1. UK Peptide Based Metabolic Disorders Therapeutics Market, Segmentation By Drug Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
16.2. UK Peptide Based Metabolic Disorders Therapeutics Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
16.3. UK Peptide Based Metabolic Disorders Therapeutics Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
17. Germany Peptide Based Metabolic Disorders Therapeutics Market
17.1. Germany Peptide Based Metabolic Disorders Therapeutics Market, Segmentation By Drug Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
17.2. Germany Peptide Based Metabolic Disorders Therapeutics Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
17.3. Germany Peptide Based Metabolic Disorders Therapeutics Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
18. France Peptide Based Metabolic Disorders Therapeutics Market
18.1. France Peptide Based Metabolic Disorders Therapeutics Market, Segmentation By Drug Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
18.2. France Peptide Based Metabolic Disorders Therapeutics Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
18.3. France Peptide Based Metabolic Disorders Therapeutics Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
19. Italy Peptide Based Metabolic Disorders Therapeutics Market
19.1. Italy Peptide Based Metabolic Disorders Therapeutics Market, Segmentation By Drug Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
19.2. Italy Peptide Based Metabolic Disorders Therapeutics Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
19.3. Italy Peptide Based Metabolic Disorders Therapeutics Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
20. Spain Peptide Based Metabolic Disorders Therapeutics Market
20.1. Spain Peptide Based Metabolic Disorders Therapeutics Market, Segmentation By Drug Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
20.2. Spain Peptide Based Metabolic Disorders Therapeutics Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
20.3. Spain Peptide Based Metabolic Disorders Therapeutics Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
21. Eastern Europe Peptide Based Metabolic Disorders Therapeutics Market
21.1. Eastern Europe Peptide Based Metabolic Disorders Therapeutics Market Overview
21.2. Eastern Europe Peptide Based Metabolic Disorders Therapeutics Market, Segmentation By Drug Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
21.3. Eastern Europe Peptide Based Metabolic Disorders Therapeutics Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
21.4. Eastern Europe Peptide Based Metabolic Disorders Therapeutics Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
22. Russia Peptide Based Metabolic Disorders Therapeutics Market
22.1. Russia Peptide Based Metabolic Disorders Therapeutics Market, Segmentation By Drug Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
22.2. Russia Peptide Based Metabolic Disorders Therapeutics Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
22.3. Russia Peptide Based Metabolic Disorders Therapeutics Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
23. North America Peptide Based Metabolic Disorders Therapeutics Market
23.1. North America Peptide Based Metabolic Disorders Therapeutics Market Overview
23.2. North America Peptide Based Metabolic Disorders Therapeutics Market, Segmentation By Drug Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
23.3. North America Peptide Based Metabolic Disorders Therapeutics Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
23.4. North America Peptide Based Metabolic Disorders Therapeutics Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
24. USA Peptide Based Metabolic Disorders Therapeutics Market
24.1. USA Peptide Based Metabolic Disorders Therapeutics Market Overview
24.2. USA Peptide Based Metabolic Disorders Therapeutics Market, Segmentation By Drug Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
24.3. USA Peptide Based Metabolic Disorders Therapeutics Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
24.4. USA Peptide Based Metabolic Disorders Therapeutics Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
25. Canada Peptide Based Metabolic Disorders Therapeutics Market
25.1. Canada Peptide Based Metabolic Disorders Therapeutics Market Overview
25.2. Canada Peptide Based Metabolic Disorders Therapeutics Market, Segmentation By Drug Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
25.3. Canada Peptide Based Metabolic Disorders Therapeutics Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
25.4. Canada Peptide Based Metabolic Disorders Therapeutics Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
26. South America Peptide Based Metabolic Disorders Therapeutics Market
26.1. South America Peptide Based Metabolic Disorders Therapeutics Market Overview
26.2. South America Peptide Based Metabolic Disorders Therapeutics Market, Segmentation By Drug Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
26.3. South America Peptide Based Metabolic Disorders Therapeutics Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
26.4. South America Peptide Based Metabolic Disorders Therapeutics Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
27. Brazil Peptide Based Metabolic Disorders Therapeutics Market
27.1. Brazil Peptide Based Metabolic Disorders Therapeutics Market, Segmentation By Drug Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
27.2. Brazil Peptide Based Metabolic Disorders Therapeutics Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
27.3. Brazil Peptide Based Metabolic Disorders Therapeutics Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
28. Middle East Peptide Based Metabolic Disorders Therapeutics Market
28.1. Middle East Peptide Based Metabolic Disorders Therapeutics Market Overview
28.2. Middle East Peptide Based Metabolic Disorders Therapeutics Market, Segmentation By Drug Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
28.3. Middle East Peptide Based Metabolic Disorders Therapeutics Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
28.4. Middle East Peptide Based Metabolic Disorders Therapeutics Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
29. Africa Peptide Based Metabolic Disorders Therapeutics Market
29.1. Africa Peptide Based Metabolic Disorders Therapeutics Market Overview
29.2. Africa Peptide Based Metabolic Disorders Therapeutics Market, Segmentation By Drug Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
29.3. Africa Peptide Based Metabolic Disorders Therapeutics Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
29.4. Africa Peptide Based Metabolic Disorders Therapeutics Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
30. Peptide Based Metabolic Disorders Therapeutics Market Competitive Landscape And Company Profiles
30.1. Peptide Based Metabolic Disorders Therapeutics Market Competitive Landscape
30.2. Peptide Based Metabolic Disorders Therapeutics Market Company Profiles
30.2.1. Pfizer Inc.
30.2.1.1. Overview
30.2.1.2. Products and Services
30.2.1.3. Strategy
30.2.1.4. Financial Performance
30.2.2. Johnson And Johnson
30.2.2.1. Overview
30.2.2.2. Products and Services
30.2.2.3. Strategy
30.2.2.4. Financial Performance
30.2.3. Roche Holding AG
30.2.3.1. Overview
30.2.3.2. Products and Services
30.2.3.3. Strategy
30.2.3.4. Financial Performance
30.2.4. Merck And Co. Inc.
30.2.4.1. Overview
30.2.4.2. Products and Services
30.2.4.3. Strategy
30.2.4.4. Financial Performance
30.2.5. AbbVie Inc.
30.2.5.1. Overview
30.2.5.2. Products and Services
30.2.5.3. Strategy
30.2.5.4. Financial Performance
31. Peptide Based Metabolic Disorders Therapeutics Market Other Major And Innovative Companies
31.1. Sanofi SA
31.2. Bristol-Myers Squibb Company
31.3. AstraZeneca PLC
31.4. Novartis AG
31.5. Takeda Pharmaceutical Company Limited
31.6. GlaxoSmithKline plc
31.7. Boehringer Ingelheim International GmbH
31.8. Eli Lilly Company
31.9. Amgen Inc.
31.10. Gilead Sciences Inc.
31.11. Novo Nordisk A/S
31.12. Teva Pharmaceutical Industries Ltd.
31.13. Regeneron Pharmaceuticals Inc.
31.14. Biogen Inc.
31.15. Vertex Pharmaceuticals Incorporated
32. Global Peptide Based Metabolic Disorders Therapeutics Market Competitive Benchmarking
33. Global Peptide Based Metabolic Disorders Therapeutics Market Competitive Dashboard
34. Key Mergers And Acquisitions In The Peptide Based Metabolic Disorders Therapeutics Market
35. Peptide Based Metabolic Disorders Therapeutics Market Future Outlook and Potential Analysis
35.1 Peptide Based Metabolic Disorders Therapeutics Market In 2028 - Countries Offering Most New Opportunities
35.2 Peptide Based Metabolic Disorders Therapeutics Market In 2028 - Segments Offering Most New Opportunities
35.3 Peptide Based Metabolic Disorders Therapeutics Market In 2028 - Growth Strategies
35.3.1 Market Trend Based Strategies
35.3.2 Competitor Strategies
36. Appendix
36.1. Abbreviations
36.2. Currencies
36.3. Historic And Forecast Inflation Rates
36.4. Research Inquiries
36.5. The Business Research Company
36.6. Copyright And Disclaimer

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook
Cookie Settings